Logos Global Management LP Instil Bio, Inc. Transaction History

Logos Global Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.37 $176,365 - $279,529	-37,928 Reduced 10.26%	331,872 $1.61 Million
Q2 2022 Aug 15, 2022	SELL	$4.21 - $11.15 $30,695 - $81,294	-7,291 Reduced 1.93%	369,800 $1.71 Million
Q1 2022 May 16, 2022	BUY	$8.48 - $18.1 $3.2 Million - $6.83 Million	377,091 New	377,091 $4.05 Million
Q4 2021 Feb 14, 2022	SELL	$15.37 - $22.5 $19.6 Million - $28.7 Million	-1,277,091 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$15.05 - $23.28 $6.32 Million - $9.77 Million	-419,759 Reduced 24.74%	1,277,091 $22.8 Million
Q2 2021 Aug 16, 2021	SELL	$15.31 - $24.63 $2.3 Million - $3.69 Million	-150,000 Reduced 8.12%	1,696,850 $32.8 Million
Q1 2021 May 17, 2021	BUY	$24.23 - $27.06 $44.7 Million - $50 Million	1,846,850 New	1,846,850 $46.3 Million

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $8.8B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.